Melanoma — the original indication establishing pembrolizumab's clinical development and the indication demonstrating the most durable long-term survival benefits — creates the clinical showcase for Keytruda's transformative oncology impact, with the Keytruda Market reflecting melanoma as the clinical proof-of-concept that established the commercial foundation.
KEYNOTE-006 long-term...
Turkish 
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt